YMAB icon

Y-mAbs Therapeutics
YMAB

Overview Fund Activity

97 hedge funds and large institutions have $716M invested in Y-mAbs Therapeutics in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 41 increasing their positions, 29 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
-3
Holders Change %
-3%
% of All Funds
1.7%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
10
Increased
41
Reduced
29
Closed
13
Calls
–
Puts
$665K
Net Calls
-$665K
Net Calls Change
-$665K

Top Buyers

1
Artisan Partners
1
Artisan Partners
Wisconsin
$48.2M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$51.5M
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$3.58M
4
SCM
4
Soleus Capital Management
Connecticut
$7.58M
5
MB
5
MPM BioImpact
Massachusetts
$12.9M

Top Sellers

1
FLAM
1
First Light Asset Management
Minnesota
$16.5M
2
CAM
2
Cormorant Asset Management
Massachusetts
$14.3M
3
TCM
3
Tekla Capital Management
Massachusetts
$0
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$122M
5
ACM
5
Ashford Capital Management
Delaware
$12.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
D.E. Shaw & Co
101
D.E. Shaw & Co
New York
– -$1.32M -39,083 Closed
HIM
102
Hillsdale Investment Management
Ontario, Canada
– -$902K -26,699 Closed
Squarepoint
103
Squarepoint
New York
– -$627K -18,554 Closed
Marshall Wace
104
Marshall Wace
United Kingdom
– -$415K -12,310 Closed
TI
105
Trexquant Investment
Connecticut
– -$294K -8,690 Closed
MWNA
106
Marshall Wace North America
New York
– -$277K -8,204 Closed
AB
107
Amalgamated Bank
New York
– -$223K -6,599 Closed
Credit Agricole
108
Credit Agricole
France
– -$118K -3,500 Closed
RDWM
109
Red Door Wealth Management
Tennessee
– -$1K -40 Closed
S
110
SignatureFD
Georgia
– -$1K -29 Closed
1 2 3 4
5